公司资料
Precipio Diagnostics 股价、新闻与催化剂
- 股票代码:
- PRPO
- 交易所:
- NASDAQ
- 行业:
- MedTech
- 所在地:
- United States
股票表现
23.90 USD (+1.70%)
收盘价
最后更新: 2026年8月17日
40.2M USD
市值
股价为何变动
The latest company update was “Precipio Announces Q2-2026 Financial Results”. PRPO changed 1.70% and closed at $23.90 on Aug 17, 2026, indicating a relatively limited closing-price reaction to this earnings update.
公司概览
Cancer Diagnostics Company
Precipio is a specialty cancer diagnostics company focused on reducing misdiagnosis in hematologic malignancies. It develops testing approaches intended to improve diagnostic accuracy for physicians, laboratories, and patients.
Integrated Clinical Laboratory
The company operates its own clinical laboratory, where it develops, validates, and uses diagnostic technologies in routine patient testing. This internal laboratory infrastructure provides a setting for generating clinical evidence and refining new assays before broader commercialization.
Products and Services Model
Precipio combines laboratory testing services with proprietary diagnostic products marketed to laboratories. This model allows the company to serve physicians directly while also distributing technologies that other laboratories can incorporate into their workflows.
未来催化剂
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。